title: Pubertal development in thalassaemic patients after allogenic bone marrow transplantation.
abstract: To obtain further insight into gonadal function, a series of 50 prepubertal patients with beta-thalassaemia major (24 boys and 26 girls) aged from 12.6 to 18 years (mean 15 years) who had received a bone marrow transplantation (BMT) during childhood or the peripubertal period, at the age of 3.6-14.5 years (mean 10.8 years), were periodically re-evaluated at intervals of 6-12 months. The last evaluation was done 1-9 years (mean 4.2 years) after BMT. At each examination we measured height, pubertal stage, plasma gonadotrophins (LH and FSH) before and after the GnRH stimulation test (i.v.), sex steroids (total and free testosterone in males, and 17 beta-oestradiol in females), serum ferritin and bone age. Fourty percent of patients entered or passed through puberty normally despite clinical and hormonal evidence of gonadal dysfunction in most of them. A correlation was not found between the pubertal stage and age at BMT, and no statistical difference between patients who did not enter into puberty and patients with spontaneous pubertal development was found in serum ferritin levels. Our data confirm that gonads in male and female thalassaemic patients are exposed to the cytotoxic effects of the preparative transplant regime with alkylating agents. In some patients absence of pubertal development was due to gonadotrophin insufficiency, probably secondary to previous iron overload. These findings emphasize the need for a vigilant long-term follow up study of thalassaemic patients who have had BMT.
authors.affiliation: Department of Paediatrics, Arcispedale S. Anna Hospital, Ferrara, Italy.
authors.forename: V
authors.initials: V
authors.lastname: De Sanctis
authors.forename: M
authors.initials: M
authors.lastname: Galimberti
authors.forename: G
authors.initials: G
authors.lastname: Lucarelli
authors.forename: E
authors.initials: E
authors.lastname: Angelucci
authors.forename: M
authors.initials: M
authors.lastname: Ughi
authors.forename: D
authors.initials: D
authors.lastname: Baronciani
authors.forename: P
authors.initials: P
authors.lastname: Polchi
authors.forename: C
authors.initials: C
authors.lastname: Giardini
authors.forename: B
authors.initials: B
authors.lastname: Bagni
authors.forename: C
authors.initials: C
authors.lastname: Vullo
mesh_terms: D000293:Adolescent; D001827:Body Height; D016026:Bone Marrow Transplantation; D002648:Child; D002657:Child Development; D004958:Estradiol / Q000097:blood; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D005500:Follow-Up Studies; D007987:Gonadotropin-Releasing Hormone; D006066:Gonads / Q000503:physiopathology; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D011627:Puberty; D013739:Testosterone / Q000097:blood; D017086:beta-Thalassemia / Q000503:physiopathology* / Q000628:therapy
chemical_list: D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone